Filip M Golebiowski (Filip Gołębiowski)

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Jinseok Kim, Chia-Lung Li, Xuemin Chen, Yanxiang Cui, Filip M Golebiowski, Huaibin Wang, Fumio Hanaoka, Kaoru Sugasawa, Wei Yang
Lesion recognition by XPC, TFIIH and XPA in DNA excision repair. Nature (2023)
Fei Mo, Zhiya Yu, Peng Li, Jangsuk Oh, Rosanne Spolski, Liang Zhao, Caleb R Glassman, Tori N Yamamoto, Yun Chen, Filip M Golebiowski, Dalton Hermans, Sonia Majri-Morrison, Lora K Picton, Wei Liao, Min Ren, Xiaoxuan Zhuang, Suman Mitra, Jian-Xin Lin, Luca Gattinoni, Jonathan D Powell, Nicholas P Restifo, K Christopher Garcia, Warren J Leonard
An engineered IL-2 partial agonist promotes CD8+ T cell stemness. Nature 597 (7877) (2021)
Piotr Pankiewicz, Marcin Szybiński, Katarzyna Kisielewska, Filip M Golebiowski, Patryk Krzemiński, Izabela Rutkowska-Włodarczyk, Rafał Moszczyński-Pętkowski, Lidia Gurba-Bryśkiewicz, Monika Delis, Krzysztof Mulewski, Damian Smuga, Jakub Dominowski, Artur Janusz, Michał Górka, Krzysztof Abramski, Agnieszka Napiórkowska, Marcin Nowotny, Krzysztof Dubiel, Katarzyna Kalita, Maciej Wieczorek, Jerzy Pieczykolan, Mikołaj Matłoka
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)

Filip M Golebiowski.css-eqlu8i{font-size:small;padding-left:4px;} (Filip Gołębiowski)